[1]
Y. Dönmez Çakıl, Z. Akbulut, G. Demirel, R. Gülhan, and Z. Ozunal, “The effects of low-dose sorafenib on epithelial-mesenchymal transition and multidrug resistance markers in HepG2 cell line”, Eur Res J, vol. 9, no. 2, pp. 367–374, Mar. 2023, doi: 10.18621/eurj.1206680.